Bumper Offer - Urjas oil Just @ Rs. 1
Laveta M Tablet is a prescription drug, available for use as Tablet. The alternative uses of Laveta M Tablet have also been explained below.
The correct dosage of Laveta M Tablet depends on the patient's age, gender, and medical history. Individual symptoms and route of administration also determines the right dosage. Refer to the dosage section for a detailed discussion.
Laveta M Tablet also has some side effects, the most common being Headache, Stomach ache, Joint pain. Normally, these side effects of Laveta M Tablet are not long lasting and go away when the treatment is finished. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Laveta M Tablet has a Severe effect for pregnant women and Severe effect on lactating mothers. It is important to know if Laveta M Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Laveta M Tablet related warnings section.
Laveta M Tablet is contraindicated in people with pre-existing medical conditions like Liver Disease as it can result in adverse effects.
Additionally, Laveta M Tablet may also adversely react with other medicines. A complete list of these interactions is given below.
Along with the above-mentioned precautions, remember that taking Laveta M Tablet is considered not safe while driving, and is not addictive.
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Is the use of Laveta M Tablet safe for pregnant women?
Laveta M should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Laveta M Tablet safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Laveta M. So it is adviced to consult the doctor before using it.
What is the effect of Laveta M Tablet on the Kidneys?
In the absence of any scientific study on the side effects of Laveta M on kidney, information on safety of Laveta M for kidney is unavailable.
What is the effect of Laveta M Tablet on the Liver?
There is no research available on the side effects of Laveta M on the liver. Therefore, its impact is unknown.
What is the effect of Laveta M Tablet on the Heart?
No research work has been carried out till date on effects of Laveta M on heart. So it is not known whether taking Laveta M will cause side effects on heart or not.
Laveta M Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Laveta M Tablet unless your doctor advises you to do so -
Is this Laveta M Tablet habit forming or addictive?
Forming a habit of Laveta M Tablet has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Laveta M Tablet. So it is best to avoid driving.
Is it safe?
Yes, but consume Laveta M Tablet only on doctor's advice.
Is it able to treat mental disorders?
Laveta M Tablet is unable to treat or cure mental disorders.
Interaction between Food and Laveta M Tablet
Due to the absence of research, it is difficult to say how Laveta M Tablet and food will interact.
Interaction between Alcohol and Laveta M Tablet
Information about the interaction of Laveta M Tablet and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xyzal® (levocetirizine dihydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 164,167
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 873-874
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 228
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Singulair® (montelukast sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Lukair® (montelukast sodium)
Product Index [Internet]: MONTAIR LC & MONTAIR LC KID DT / Syrup (Montelukast sodium + Levocetirizine dihydrochloride ). Ciplamed
Highlights of Prescribing Information [Internet]: XYZAL® (levocetirizine dihydrochloride) tablets . Initial U.S. Approval: 19952007
Smpc [Internet]: montelukast sodium. Aurobindo Pharma
Package leaflet Information for the patient [Internet]: Xyzal 0.5 mg/ml oral solution. UCB Pharma Ltd